A lung cancer surgery study to test a special imaging dye
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a dye called abenacianine (VGT-309) that may help surgeons see cancer more clearly during lung surgery. It looks at whether the dye is safe and effective for identifying cancer in people having surgery to remove a lung lesion or mass.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be scheduled for surgery to remove a lung lesion or mass, with the goal of diagnosis or cure.
- You must be able to have surgery based on your surgical team's assessment.
- If you are a woman able to have children, you must not be pregnant or nursing and must use highly effective birth control from screening until 30 days after treatment.
- If you are a man not surgically sterilized and having sex with a woman able to have children, you must use highly effective birth control from screening until 30 days after treatment.
- You must not have taken part in another experimental trial in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special imaging drug (IRDye800CW-nimotuzumab) that may help surgeons better see lung cancer tissue during planned lung surgery. Phase 1/2 looks mainly at safety and how well the imaging works to guide the operation.
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.